Literature DB >> 10993492

Dopamine transporter binding in Gilles de la Tourette syndrome.

K R Müller-Vahl1, G Berding, T Brücke, H Kolbe, G J Meyer, H Hundeshagen, R Dengler, W H Knapp, H M Emrich.   

Abstract

Preliminary studies in patients with Gilles de la Tourette syndrome (TS) provided evidence of presynaptic dopaminergic dysfunction, demonstrating increased reuptake sites. Therefore we investigated striatal dopamine transporter binding in 12 TS patients and 9 control subjects using single photon emission computed tomography and 123I-labeled 2beta-carbomethoxy-3beta-(4-iodophenyl)tropane. In TS patients we found significantly higher relative striatal activity ratios (mean +/- SD 12.33 +/- 3.58) than in controls (9.36 +/- 1.35, P< 0.05). Only five patients, however, showed striatum/occipital cortex ratios more than 2 SD above the normal means. Seven patients had activity ratios within the average ratio of the control group plus 2 SD. Regarding the relationship between clinical parameters and striatum/occipital cortex ratios, we found an association between binding ratios and "self-injurious behavior" and "lack of impulse control." This study corroborates previous data suggesting an involvement of the dopaminergic system in TS pathology. Our results demonstrate that an increase in dopamine transporter capacity is a possible but not a necessary alteration, and which appears more likely when self-injurious behavior and lack of impulse control are associated.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10993492     DOI: 10.1007/pl00007806

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  14 in total

1.  Reversible dementia in Paget's disease.

Authors:  Y P Chan; K K Shui; R R Lewis; M T Kinirons
Journal:  J R Soc Med       Date:  2000-11       Impact factor: 5.344

2.  Sucking noise and collapse after central venous catheter removal.

Authors:  B Madden; P Paruchuru; H Kunst
Journal:  J R Soc Med       Date:  2000-11       Impact factor: 5.344

3.  Hermansky-Pudlak syndrome presenting with subdural haematoma and retinal haemorrhages in infancy.

Authors:  I M Russell-Eggitt; D A Thompson; K Khair; R Liesner; I M Hann
Journal:  J R Soc Med       Date:  2000-11       Impact factor: 5.344

4.  Femoral vein obstruction with an arthritic hip.

Authors:  H A Vohra; B Jones
Journal:  J R Soc Med       Date:  2000-11       Impact factor: 5.344

Review 5.  Neurobiological substrates of Tourette's disorder.

Authors:  James F Leckman; Michael H Bloch; Megan E Smith; Daouia Larabi; Michelle Hampson
Journal:  J Child Adolesc Psychopharmacol       Date:  2010-08       Impact factor: 2.576

6.  Elevated striatal dopamine transporter in a drug naive patient with Tourette syndrome and attention deficit/ hyperactivity disorder: positive effect of methylphenidate.

Authors:  Klaus-Henning Krause; Stefan Dresel; Johanna Krause; Hank F Kung; Klaus Tatsch; Hanns Lochmüller
Journal:  J Neurol       Date:  2002-08       Impact factor: 4.849

7.  Chorea-acanthocytosis in monozygotic twins: clinical findings and neuropathological changes as detected by diffusion tensor imaging, FDG-PET and (123)I-beta-CIT-SPECT.

Authors:  Kirsten R Müller-Vahl; Georg Berding; Hinderk M Emrich; Thomas Peschel
Journal:  J Neurol       Date:  2007-02-08       Impact factor: 4.849

Review 8.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

9.  Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome.

Authors:  R L Albin; R A Koeppe; K Wernette; W Zhuang; T Nichols; M R Kilbourn; K A Frey
Journal:  Neurology       Date:  2009-04-21       Impact factor: 9.910

10.  Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings.

Authors:  Gabriel S Dichter; Cara A Damiano; John A Allen
Journal:  J Neurodev Disord       Date:  2012-07-06       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.